ArticleCancer discovery2014

L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.

Eun-Hee Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.